Chartwell Investment Partners’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-57,626
Closed -$4.44M 418
2024
Q2
$4.44M Sell
57,626
-16,000
-22% -$1.17M 0.16% 197
2024
Q1
$5.04M Buy
73,626
+20,000
+37% +$1.29M 0.17% 184
2023
Q4
$3.1M Hold
53,626
0.11% 241
2023
Q3
$2.83M Hold
53,626
0.11% 240
2023
Q2
$2.9M Buy
+53,626
New +$2.8M 0.11% 247
2020
Q4
Sell
-57,953
Closed -$2.21M 428
2020
Q3
$2.21M Sell
57,953
-114,592
-66% -$4.42M 0.08% 260
2020
Q2
$6.06M Buy
172,545
+267
+0.2% +$9.62K 0.23% 165
2020
Q1
$5.62M Hold
172,278
0.26% 142
2019
Q4
$7.79M Sell
172,278
-26,016
-13% -$1.09M 0.26% 154
2019
Q3
$8.07M Sell
198,294
-347
-0.2% -$14.7K 0.27% 154
2019
Q2
$8.54M Sell
198,641
-6,755
-3% -$260K 0.28% 144
2019
Q1
$7.88M Hold
205,396
0.25% 148
2018
Q4
$7.26M Buy
205,396
+79,540
+63% +$2.88M 0.26% 135
2018
Q3
$4.84M Buy
125,856
+12,386
+11% +$433K 0.14% 215
2018
Q2
$3.71M Buy
+113,470
New +$3.42M 0.11% 250

Other funds holding BSX

Chartwell Investment Partners's BSX Position: Q3 2024 in Review

Chartwell Investment Partners sold out of Boston Scientific (BSX) in Q3 2024, closing a stake of 57,626 shares — an estimated $4.44M sold.

Chartwell Investment Partners first reported a position in BSX in Q2 2018 and held it in 15 quarters. The position peaked at $8.54M in Q2 2019. 1,395 funds tracked by Wall St. Rank hold BSX as of Q3 2024.

  • Chartwell Investment Partners reported no remaining Boston Scientific position as of Q3 2024 after selling out during the quarter.
  • Chartwell Investment Partners sold 57,626 Boston Scientific shares in Q3 2024, an estimated $4.44M.
  • Chartwell Investment Partners first reported a position in Boston Scientific in Q2 2018 and held it in 15 quarters.
  • Chartwell Investment Partners's Boston Scientific position peaked at $8.54M in Q2 2019.
  • 1,395 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2024.

Based on Chartwell Investment Partners's 13F filing for Q3 2024, filed 4 Nov 2024.